Post-coronarography application of continuous veno-venous hemofiltration in the prevention of contrast nephropathy in patients with complex multisystem deficiency

In Vivo

Volumn 22, Issue 1, 2008, Pages 123-130

  La Manna, Gaetano ^a   Pancaldi, Leonardo ^b   Dalmastri, Vittorio ^a   Cuna, Vania ^a   Capecchi, Alessandro ^b   Comai, Giorgia ^a   Persici, Elisa ^a   Bacchi, Giuliana ^a   Cianciolo, Giuseppe ^a   Lombardi, Alessandro ^b   Marrozzini, Cinzia ^a   Colì, Luigi ^a   Stefoni, Sergio ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b Ospedale di Bentivoglio   (Italy)

Author keywords

Contrast medium; Contrast nephropathy; Coronarography; CVVH; Kidney failure

Indexed keywords

CREATININE; IODINATED CONTRAST MEDIUM; IODIXANOL;

ACUTE HEART INFARCTION; ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; CHRONIC KIDNEY DISEASE; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; COMORBIDITY; CONTINUOUS HEMOFILTRATION; CONTRAST MEDIUM INDUCED NEPHROPATHY; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CREATININE BLOOD LEVEL; DIABETES MELLITUS; DISEASE SEVERITY; DRUG SAFETY; FEMALE; GLOMERULUS FILTRATION RATE; HEART EJECTION FRACTION; HEART FAILURE; HIGH RISK PATIENT; HUMAN; HYPERTENSION; HYPOTENSION; INTERVENTIONAL RADIOLOGY; MALE; NEPHROTOXICITY; OUTCOME ASSESSMENT; TRANSLUMINAL CORONARY ANGIOPLASTY;

EID: 40749128867     PISSN: 0258851X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. Mehran R and Nikolsky E: Contrast induced nephropathy: definition, epidemiology and patients at risk. Kidney Int Suppl 69: S11-S15, 2006.
2. Nash K, Hafeez A and Hou S: Hospital-acquired renal insufficiency. Am J Kidney Dis 39(5): 930-936, 2002.
3. Goldenberg I and Matetzky S: Nephropathy induced by contrast media: pathogenesis, risk factors and preventive strategies. CMAJ 172(11): 1461-1471, 2005.
4. Parfrey P: The clinical epidemiology of contrast induced nephropathy. Cardiovasc Intervent Radio 28: S3-S11, 2005.
5. Toprak O and Cirit M: Risk factors for contrast induced nephropathy. Kidney Blood Press Res 29(2): 84-93, 2006.
6. McCullogh PA, Adam A, Becker CR, Davidson C, Lameire N, Stacul F, Tumlin J and CIN Consensus Working Panel: Risk prediction of contrast induced nephropathy. Am J Cardiol 98(6A): 27K-36K, 2006.
7. Gruberg L, Mintz GS, Mehran R, Dangas G, Lansky AJ, Kent KM, Pichard AD, Satler LF and Leon MB: The prognostic implications of further renal function deterioration within 48 h of interventional coronary procedures in patients with preexistent chronic renal insufficiency. J Am Coll Cardiol 36: 1542-1548, 2000.
8. Gruberg L, Dangas G, Mehran R, Mintz GS, Kent KM, Pichard AD, Satler LF, Lansky AJ, Stone GW and Leon MB: Clinical outcome following percutaneous coronary interventions in patients with chronic renal failure. Cathet Cardiovasc Intervent 55: 66-72, 2002.
9. Papafaklis MI, Naka KK, Papamichael ND, Kolios G, Sioros L, Sclerou V, Katsouras CS and Michalis LK: The impact of renal function on the long-term clinical course of patients who underwent percutaneous coronary interventions. Cathet Cardiovasc Intervent 69: 189-197, 2007.
10. Persson PB and Tepel M: Contrast medium induced nephropathy: the pathophysiology. Kidney Int Suppl 69: S8-S10, 2006.
11. Hizoh I and Haller C: Radiocontrast induced renal tubular cell apoptosis. Invest Radiol 37: 428-434, 2002.
12. Berg KJ: Nephrotoxicity related to contrast media. Scand J Urol Nephrol 34: 317-322, 2000.
13. Heyman SN, Rosenberger C and Rosen S: Regional alterations in renal haemodynamics and oxygenation: a role in contrast medium-induced nephropathy. Nephrol Dial Transplant 20: i6-i11, 2005.
14. Tumil J, Stacul F, Adam A, Becker CR, Davidson C, Lameire N, McCullough PA and CIN Consensus Working Panel: Pathophysiology of contrast induced nephropathy. Am J Cardiol 98: 14K-20K, 2006.
15. Marenzi G and Bartorelli AL: Recent advances in the prevention of radioCN. Curr Opin Crit Care 10: 505-509, 2004.
16. Stevens MA, McCullogh PA, Tobin KJ, Speck JP, Westveer DC, Guido-Allen DA, Timmis GC and O'Neill WW: A prospective randomized trial of prevention measures in patients at high risk for contrast nephropathy. Result of the P.R.I.N.C.E. study. J Am Coll Cardiol 33: 403-411, 1999.
17. Trivedi HS, Moore H, Nasr S, Aggarwal K, Agrawal A, Goel P and Hewett J: A randomized prospective trial to assess the role of saline hydration on the development of contrast nephrotoxicity. Nephron Clin Pract 93: c29-c34, 2003.
18. Bader BD, Berger ED, Heede MB, Silberbaur I, Duda S, Risler T and Erley CM: What is the best hydration regimen to prevent contrast media induced nephotoxicity? Clin nephrol 62: 1-7, 2004.
19. Taylor AJ, Hotchkiss D, Morse RW and McCabe J: Preparation for angiography in renal dysfunction: a randomized trial of inpatient vs. outpatient hydration protocols for cardiac catheterization in mild-to-moderate renal dysfunction. CHEST 114: 1570-1574, 1998.
20. Muller C: Prevention of contrast induced nephropathy with volume supplementation. Kidney Int 69: S16-S19, 2006.
21. Merten GJ, Burgess WP, Gray LV, Holleman JH, Roush TS, Kowalchuk GJ, Bersin RM, Van Moore A, Simonton CA, Rittase RA, Norton HJ and Kennedy TP: Prevention of contrast induced nephropathy with sodium bicarbonate. A randomized controlled trial. JAMA 291: 2328-2334, 2004.
22. Tepel M, Van der Giet M, Schwarzfeld C, Laufer U, Liermann D and Zidek W: Prevention of radiographic contrast agent induced reductions in renal function by acetylcysteine. N Engl J Med 343: 180-184, 2000.
23. Marenzi G, Marana I, Lauri G, Assanelli E, Grazi M, Campodonico J, Trabattoni F, Fabbiocchi F, Montorsi P and Bartorelli AL: The prevention of radiocontrast agent induced nephropathy by hemofiltration. N Engl J Med 349: 1333-1340, 2003.
24. Marenzi G, Lauri G, Campodonico J, Marana I, Assanelli I, De Metrio M, Grazi M, Veglia F, Fabbiocchi F, Montorsi P and Bartorelli AL: Comparison of two hemofiltration protocols for prevention of contrast induced nephropathy in high-risk patients. Am J Med 119: 155-162, 2006.
25. Lehnert T, Keller E, Gondolf K, Schäffner T, Pavenstädt H and Schollmeyer P: Effect of haemodialysis after contrast medium administration in patients with renal insufficiency. Nephrol Dial Transplant 13: 358-362, 1998.
26. Shinoda T, Hata T, Nakajima K, Yoshimoto H and Niwa A: Time-course of iodine elimination by hemodialysis in patients with renal failure after angiography. Ther Apher 6: 437-442, 2002.
27. Vogt B, Ferrari P, Schönholzer C, Marti HP, Mohaupt M, Wiederkehr M, Cereghetti C, Serra A, Huynh-Do U, Uehlinger D and Frey FJ: Prophylactic hemodialysis after radiocontrast media in patients with renal insufficiency is potentially harmful. Am J Med 111: 692-698, 2001.
28. Huber W, Jeschke B, Kreymann B, Hennig M, Page M, Salmhofer H, Eckel F, Schmidt U, Umgelter A, Schweigart U and Classen M: Haemodialysis for the prevention of CN: outcome of 31 patients with severely impaired renal function, comparison with patients at similar risk and review. Invest Radiol 37: 471-481, 2002.
29. Sterner G, Frennby B, Kurkus J and Nyman U: Does post-angiographic hemodialysis reduce the risk of contrast induced nephropathy? Scand J Urol Nephrol 34: 323-326, 2000.
30. Kawashima S, Takano H, Iino Y, Takayama M and Takano T: Prophylactic hemodialysis does not prevent contrast induced nephropathy after cardiac catheterization in patients with chronic renal insufficiency. Circ J 70: 553-558, 2006.
31. Hsieh YC, Ting CT, Liu TJ, Wang CH, Chen YT and Lee WL: Short- and long-term renal outcomes of immediate prophylactic hemodialysis after cardiovascular catheterizations in patients with severe renal insufficiency. Int J Cardiol 101: 407-413, 2005.
32. Reinecke H, Fobker M, Wellmann J, Becke B, Fleiter J, Heitmeyer C, Breithardt G, Hense HW and Schaefer RM: A randomized controlled trial comparing hydration therapy to additional hemodialysis or N-acetylcysteine for the prevention of contrast medium induced nephropathy. Clin Res Cardiol 96: 130-139, 2007.
33. Gami AS and Garovic VD: Contrast nephropathy after coronary angiography. Mayo Clinic Proc 79: 211-219, 2004.
34. Murphy SW, Barrett BJ and Parfrey PS: Contrast nephropathy. J Am Soc of Nephrol 11: 177-182, 2000.
35. Mehran R, Aymong ED, Nikolsky E, Lasic Z, Iakovou I, Fahy M, Mintz GS, Lansky AJ, Moses JW, Stone GW, Leon MB and Dangas G: A simple risk score for prediction of CN after percutaneous coronary intervention: development and initial validation. J Am Coll Cardiol 44: 1393-1399, 2004.
36. Marenzi G, Bartorelli A, Lauri G, Assanelli E, Grazi M, Campodonico J and Marana I: Continuous veno-venous hemofiltration for the treatment of contrast induced acute reanl failure after percutaneous coronary interventions. Cathet Cardiovasc Intervent 58: 59-64, 2003.
37. Schindler R, Sthal C, Venz S, Ludat K, Krause W and Frei U: Removal of contrast media by different extracorporeal treatments. Nephrol Dial Transplant 16: 1471-1474, 2001.
38. Van den Berk G, Tonino S, De Fijter C, Smit W and Schultz MJ: Bench to bedside review: preventive measures for CN in critically ill patients. Critical Care 9: 361-370, 2005.
39. Klarenbach SW, Pannu N, Tonelli MA and Manns BJ: Cost-effectiveness of hemofiltration to prevent contrast nephropathy in patients with chronic kidney disease. Crit Care Med 34: 1044-1051, 2006.
40. Rodby RA: Preventing complications of radiographic contrast media: is there a role for dialysis? Semin Dial 1: 19-23, 2007.
41. Heering P, Morgera S, Schmitz FJ, Schmitz G, Willers R, Schultheiss HP, Strauer BE and Grabensee B: Cytokine removal and cardiovascular hemodynamics in septic patients with continuous venovenous hemofiltration. Intensive Care Med 13(3): 288-296, 1997.
42. Story DA, Ronco Cand Bellomo R: Trace element and vitamin concentrations and losses in critically ill patients treated with continuous venovenous hemofiltration. Crit Care Med 27(1): 220-223, 1999.
43. Bouman SC, De Pont JM, Meijers CM, Bakhtiari K, Roem D, Zeerleder S, Wolbink G, Korevaar JC, Levi M and De Longe E: The effects of continuous venovenous hemofiltration on coagulation activation. Crit Care 10: 1-8, 2006.
44. Toft P, Nilsen U, Bollen P, Lillevang S, Olsen KE, Brøchner AC and Larsen NH: The impact of long-term haemofiltration (continuous veno-venous haemofiltration) on cell-mediated immunity during endotoxaemia. Acta Anaesthesiol Scand 51: 679-686, 2007.
45. Barenbrock M, Hausberg M, Matzkies F, De la Motte S and Schaefer RM: Effects of bicarbonate- and lactate-buffered replacement fluids on cardiovascular outcome in CVVH patients. Kidney Int 58: 1751-1757, 2000.